Back to discover
Drug
Ebola Vaccines
Research stageEmerging research
1
Research papers
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this drug.
Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases.
Research2024-09-03Nature communications
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Canonical name
Ebola Vaccines
RxNorm CUI
469933
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes5
CD4-Positive T-Lymphocytes1Ebola Vaccines1Ebolavirus1Hemorrhagic Fever, Ebola1Immunity, Cellular1
Journals, researchers & institutions
Top journals
- Nature communications1
Leading researchers
- Béavogui AH1
- Bérerd-Camara M1
- Foucat E1
- Guillaumat L1
- Huchon M1
- Lacabaratz C1
- Lévy Y1
- Lhomme E1
Leading institutions
free-text, unnormalised
- Centre National de Formation et de Recherche en Santé Rurale (CNFRSR)1
- Institut Bergonié1
- Institut Mondor de Recherche Biomedicale (IMRB)1
- Population Health Research Center1
- Vaccine Research Institute1
References & data sources
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature